Gastroprotective effects of pantoprazole against experimental mucosal damage

Fundamental and Clinical Pharmacology

Volumn 14, Issue 2, 2000, Pages 89-99

  Blandizzi, Corrado ^a   Natale, Gianfranco ^a   Gherardi, Giorgio ^b   Lazzeri, Gloria ^a   Marveggio, Cristina ^b   Colucci, Rocchina ^a   Carignani, Diego ^a   Del Tacca, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Hospital of Sondrio   (Italy)

Author keywords

Gastric damage; Mucus secretion; Pantoprazole; Prostaglandins; Sulfhydryl radicals

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; AMINOPHYLLINE; ATROPINE; CAPSAICIN; INDOMETACIN; N ETHYLMALEIMIDE; N(G) NITROARGININE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; SURAMIN;

ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HISTOPATHOLOGY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; STOMACH ACID SECRETION; STOMACH INJURY; STOMACH MUCOSA; STOMACH PROTECTION;

EID: 0034118995     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2000.tb00396.x     Document Type: Article

References (53)

1. [1] Richardson P., Hawkey C.J., Stack W.A., Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders, Drugs 56 (1998) 307-335.
2. +)ATPase, Nature 290 (1981) 159-161.
3. [3] Szabo S., Szelenyi I., Cytoprotection in gastrointestinal pharmacology, Trends Pharmacol. Sci. 8 (1987) 149-154.
4. [4] Konturek S.J., Brzozowski T., Radecki T., Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats, Digestion 27 (1983) 159-164.
5. [5] Mattsson H., Andersson K., Larsson H., Omeprazole provides protection against experimentally induced gastric mucosal lesions, Eur. J. Pharmacol. 91 (1983) 111-114.
6. [6] Blandizzi C., Gherardi G., Marveggio C., Natale G., Carignani D., Del Tacca M., Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats, Digestion 56 (1995) 220-229.
7. [7] Blandizzi C., Gherardi G., Natale G., Marveggio C., Del Tacca M., Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats, Dig. Dis. Sci. 39 (1994) 2109-2117.
8. [8] Blandizzi C., Natale G., Gherardi G., Lazzeri G., Marveggio C., Colucci R., Carignani D., Del Tacca M., Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury, Dig. Dis. Sci. 44 (1999) 2039-2050.
9. [9] Fukuda T., Arakawa T., Shimizu Y., Ohtani K., Higuchi K., Kobayashi K., Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa, J. Clin. Gastroenterol. Suppl. 2 20 (1995) S5-S7.
10. [10] Fitton A., Wiseman L., Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders, Drugs 51 (1996) 460-482.
11. 2 receptor antagonist in the rat, Pharmacology 41 (1990) 333-337.
12. +-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole, J. Gastroenterol. Hepatol. 14 (1999) 251-257.
13. [13] Højgaard L., Mertz Nielsen A., Rune S.J., Peptic ulcer pathophysiology: acid, bicarbonate, and mucosal function, Scand. J. Gastroenterol. Suppl. 216 31 (1996) 10-15.
14. [14] Szabo S., Trier J.S., Frankel P.W., Sulfhydryl compounds may mediate gastric cytoprotection, Science 214 (1981) 200-202.
15. [15] Wallace J.L., Granger D.N., The cellular and molecular basis of gastric mucosal defence, FASEB J. 10 (1996) 731-740.
16. [16] Kromer W., Postius S., Riedel R., Simon W.A., Hanauer G., Brand U., Gonne S., Parsons M.E., BY 1023/SK & F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions, J. Pharmacol. Exp. Ther. 254 (1990) 129-135.
17. [17] Lacy E.R., Ito S., Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin, Gastroenterology 83 (1982) 619-625.
18. [18] Woodruff G.N., Hughes J., Cholecystokinin antagonists, Annu. Rev. Pharmacol. Toxicol. 31 (1991) 469-501.
19. [19] Voogd T.E., Vansterkenburg E.L.M., Wilting J., Janssen L.H.M., Recent research on the biological activity of suramin, Pharmacol. Rev. 45 (1993) 177-203.
20. [20] Blandizzi C., Gherardi G., Marveggio C., Lazzeri G., Natale G., Carignani D., Colucci R., Del Tacca M., Suramin enhances ethanol-induced injury to gastric mucosa in rats, Dig. Dis. Sci. 42 (1997) 1233-1241.
21. [21] Pabst M.A., Schoninkle E., Holzer P., Ablation of capsaicin-sensitive afferent nerves impairs defence but not rapid repair of rat gastric mucosa, Gut 34 (1993) 897-903.
22. [22] Peskar B.M., Respondek M., Muller K.M., Peskar B., A role for nitric oxide in capsaicin-induced gastroprotection, Eur. J. Pharmacol. 198 (1991) 113-114.
23. [23] Konturek P.K., Brzozowski T., Konturek S.J., Dembinski A., Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions, Gastroenterology 99 (1990) 1607-1615.
24. [24] Oates P.J., Hakkinen J.P., Studies on the mechanism of ethanol-induced gastric damage in rats, Gastroenterology 94 (1988) 10-21.
25. [25] Ruwart M.J., Lancaster C., Nezamis J.E., Davis J.P., Rush B.D., Friedle N.M., Pugh C., Timoprazole: a unique antisecretory and cytoprotective agent, Gastroenterology 82 (1982) A1166.
26. [26] Kawano S., Tanimura H., Sato N., Tsuji S., Takei Y., Ogihara T., Nagano K., Fusamoto H., Kamada T., Effects of proton pump inhibitor on gastric mucosa hemodynamics and tissue oxygenation in anesthetized rats, Eur. J. Pharmacol. 211 (1992) 55-60.
27. [27] Wallace J.L., Whittle B.J.R., The role of extracellular mucus as a protective cap over gastric mucosal damage, Scand. J. Gastroenterol. Suppl. 215 21 (1986) 79-85.
28. [28] Ito S., Lacy E.R., Morphology of rat gastric mucosal damage, defence, and restitution in the presence of luminal ethanol, Gastroenterology 88 (1985) 250-260.
29. [29] Konturek S.J., Mechanisms of gastroprotection, Scand. J. Gastroenterol. Suppl. 174 25 (1990) 1-28.
30. [30] Okabe S., Nozue C., Amagase K., Mechanism by which omeprazole and leminoprazole enhance healing of acetic acid gastric ulcers in rats: role of circulating gastrin, in: Cheli R., Iaquinto G., Szabo S. (Eds.), Gastroduodenal Mucosal Damage: Problems of Protection and Healing, Mediserve, Milan, 1997, p. 169.
31. [31] Alison M.R., Chinery R., Poulsom R., Ashwood P., Longcroft J.M., Wright N.A., Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach, J. Pathol. 175 (1995) 405-414.
32. [32] Folkman J., Szabo S., Stovroff M., McNeil P., Li W., Shing Y., Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing, Ann. Surg. 214 (1991) 414-427.
33. [33] Okita K., Korita M., Nakamishi N., Tekemoto T., Role of epidermal growth factor in protection and repair of gastric mucosal injury, J. Clin. Gastroenterol. Suppl. 1 13 (1991) S103-S108.
34. [34] Romano M., Polk W.H., Awad J.A., Arteaga C.L., Nanney L.B., Wargovich M.J. et al., Transforming growth factor-α protection against drug-induced injury to the rat gastric mucosa in vivo, J. Clin. Invest. 90 (1992) 2409-2421.
35. [35] Surrenti C., Milani S., Palatini I., Orsini B., Salvadori G., Calabró A., Role of epidermal growth factor (EGF) in the healing of human gastric ulcer, Dig. Dis. Sci. 38 (1993) A12.
36. [36] Matsukura H., Masuda M., Uchida A., Kamishiro T., Effects of NC-1300-O-3 on gastric mucus secretion and prostaglandin release in rats, Jpn. J. Pharmacol. 65 (1994) 319-326.
37. [37] Hell M., Sewing K.F., Effect of omeprazole on eicosanoid formation in and release from guinea pig mucosal cells, Br. J. Pharmacol. 91 (1987) 69-75.
38. 2: an in vitro study, J. Clin. Gastroenterol. Suppl. 1 17 (1993) S15-S21.
39. [39] Dupuy D., Szabo S., Protection by metals against ethanol-induced gastric mucosal injury in the rat: comparative biochemical and pharmacological studies implicate protein sulfhydryls, Gastroenterology 91 (1986) 966-974.
40. [40] Mutoh H., Hiraishi H., Ota S., Yoshida H., Ivey K., Terano A., Sugimoto T., Protective role of intracellular glutathione against ethanol-induced damage in cultured rat gastric mucosal cells, Gastroenterology 98 (1990) 1452-1459.
41. [41] Tepperman B.L, Jacobson E.D., Circulatory factors in gastric mucosal defence and repair, in: Johnson L.R. (Ed.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1994, p. 1331.
42. [42] Takeuchi K., Okada M., Niida H., Okabe S., Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection, J. Pharmacol. Exp. Ther. 248 (1989) 836-841.
43. [43] Hirota M., Inoue M., Ando Y., Hirayama K., Morino Y., Sakamoto K., Mori K., Akagi M., Inhibition of stress-induced gastric injury in the rat by glutathione, Gastroenterology 97 (1989) 853-859.
44. [44] Takeuchi K., Okada M., Niida H., Okabe S., Dual effects of N-ethylmaleimide on ethanol-induced gastric lesions in rats, Dig. Dis. Sci. 36 (1991) 870-879.
45. [45] Matsukura H., Masuda M., Kawaguchi K., Uchida A., Kamishiro T., Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats, Jpn. J. Pharmacol. 65 (1994) 9-18.
46. [46] Holm-Rutili L., Effects of omeprazole on gastric mucosal microcirculation and acid secretion in the rat, Gastroenterology 92 (1987) 716-723.
47. [47] Hui W.M., Chen B.W., Cho C.H., Luk C.T., Lam S.K., Role of gastric mucosal blood flow in cytoprotection, Digestion 48 (1991) 113-120.
48. [48] Mertz-Nielsen A., Hillingso J., Bukhave K., Rask-Madsen J., Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans, Gut 38 (1996) 6-10.
49. [49] Holzer P., Livingston E.H., Guth P.H., Neural, metabolic, physical, and endothelial factors in the regulation of gastric circulation, in: Johnson L.R. (Ed.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1994, p. 1311.
50. +-ATPase inhibitor with an improved pH stability, Eur. J. Pharmacol. 218 (1992) 265-271.
51. [51] Shin J.M., Besancon M., Prinz C., Simon A., Sachs G., Continuing development of acid pump inhibitors: site of action of pantoprazole, Aliment. Pharmacol. Ther. Suppl. 1 8 (1994) 11-23.
52. [52] Schepp W., Rehner M., Witzel L., A review of treatment of duodenal and gastric ulcers - pantoprazole vs. omeprazole, Aliment. Pharmacol. Ther. Suppl. 1 8 (1994) 53-57.
53. [53] Levy M.J., Seelig C.B., Robinson N.J., Ranney J.E., Comparison of omeprazole and ranitidine for stress ulcer prophylaxis, Dig. Dis. Sci. 42 (1997) 1255-1259.